Roche Holding Ownership

RHHBY Stock  USD 35.44  0.15  0.43%   
Roche Holding owns a total of 6.4 Billion outstanding shares. Roughly 98.73 pct. of Roche Holding outstanding shares are held by general public with 1.27 (%) by third-party entities. On August 15, 2024, Representative Josh Gottheimer of US Congress acquired under $15k worth of Roche Holding's common stock.
Some institutional investors establish a significant position in otc stocks such as Roche Holding in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Roche Holding, and when they decide to sell, the otc stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
  
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Roche Holding Ltd. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.

Roche OTC Stock Ownership Analysis

The company last dividend was issued on the 16th of March 2023. Roche Holding had 2:1 split on the 27th of February 2014. Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Switzerland, Germany, the United States, Austria, Netherlands, the United Kingdom, France, Belgium, and internationally. The company was founded in 1896 and is headquartered in Basel, Switzerland. Roche Holdings operates under Drug ManufacturersGeneral classification in the United States and is traded on OTC Exchange. It employs 100920 people.The quote for Roche Holding Ltd is listed on Over The Counter exchange (i.e., OTC), and the entity is not required to meet listing requirements such as those found on the Nasdaq, NYSE, or AMEX exchanges. To find out more about Roche Holding Ltd contact William Anderson at 41 61 688 11 11 or learn more at https://www.roche.com.

Roche Holding's latest congressional trading

Congressional trading in companies like Roche Holding, is subject to rigorous scrutiny to prevent conflicts of interest and insider trading. This is governed by multiple SEC regulations which were established to foster transparency and deter members of Congress from leveraging non-public information for personal gain. This oversight helps maintain public trust and ensures that investments in Roche Holding by those in governmental positions are based on the same information available to the general public.
2024-08-15Representative Josh GottheimerAcquired Under $15KVerify
2024-07-09Representative Josh GottheimerAcquired Under $15KVerify
2023-04-25Representative Daniel MeuserAcquired Under $15KVerify
2023-03-30Representative Daniel MeuserAcquired Under $15KVerify

Roche Holding Outstanding Bonds

Roche Holding issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Roche Holding uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Roche bonds can be classified according to their maturity, which is the date when Roche Holding Ltd has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Roche OTC Stock Analysis

When running Roche Holding's price analysis, check to measure Roche Holding's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Roche Holding is operating at the current time. Most of Roche Holding's value examination focuses on studying past and present price action to predict the probability of Roche Holding's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Roche Holding's price. Additionally, you may evaluate how the addition of Roche Holding to your portfolios can decrease your overall portfolio volatility.